Details for 2016779272

Up to date per 03.04.2026

Actions

Title / Product Name

KOMBINATION EINES PD-1-ACHSEN-BINDUNGSANTAGONISTEN UND EINES ALK-INHIBITORS ZUR BEHANDLUNG VON ALK-NEGATIVEM KREBS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2016779272

EP Publication Number

3355902

E-Number

1482867

Language

PCT Number

US16053939

Publication Date

08.08.2018 A

13.04.2022 B1

Registration Date

13.04.2022

AT Publication Date

15.05.2022

Application Date

27.09.2016

Registration Number

Priorities

30.09.2015

201562235406 P

09.09.2016

201662385430 P

12.09.2016

201662393609 P

IPC

A61K 31/439 20060101AFI20211130BHEP

Maximum Duration of Protection

27.09.2036

Owner

Merck Patent GmbHFrankfurter Strasse 250 64293 DarmstadtDE

Pfizer Inc.235 East 42nd Street New York, NY 10017US

Representative

No representatives present

Inventor

LIN, Chia-Yang735 Coastland Drive Palo Alto, California 94303US

PRIOR, Wei Wei Wu602 Spar Drive Redwood City, CA 94065US

QU, Yan720 Toulouse Court Half Moon Bay, California 94019US

WANG, Changyu32264 Ashley Way Union City, California 94587US